[
  {
    "ts": null,
    "headline": "Edwards says eight-year data confirm long-term durability of Resilia tissue",
    "summary": "Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary Resilia tissue technology have significantly improved long-term outcomes compared to those receiving non-Resilia tissue bioprosthetic valves. Presented at the Heart Valve Society Annual Meeting, the study of 947 patients marks the first long-term, propensity-matched comparison between Resilia tissue and non-Resilia tissue surgical aortic valves. The Resilia",
    "url": "https://finnhub.io/api/news?id=8c21d20171ac966d0aad2b6fc55595b66a066be4472d92788fe9aaad3ce77710",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745065532,
      "headline": "Edwards says eight-year data confirm long-term durability of Resilia tissue",
      "id": 134023105,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary Resilia tissue technology have significantly improved long-term outcomes compared to those receiving non-Resilia tissue bioprosthetic valves. Presented at the Heart Valve Society Annual Meeting, the study of 947 patients marks the first long-term, propensity-matched comparison between Resilia tissue and non-Resilia tissue surgical aortic valves. The Resilia",
      "url": "https://finnhub.io/api/news?id=8c21d20171ac966d0aad2b6fc55595b66a066be4472d92788fe9aaad3ce77710"
    }
  }
]